Sun L, Zheng ZM, Shao CS, Zhang ZY, Li MW, Wang L, Wang H, Zhao GH, Wang P (2022) Rational design by structural biology of industrializable, long-acting antihyperglycemic GLP-1 receptor agonists
Some people may prefer a pill over an injectable, and most importantly, oral medications are more cost-effective to create, so they are less expensive and more accessible. The pills are slightly less effective than injectable semaglutide: Studies found that people who took 25 or 50 mg doses of oral semaglutide for 14 months lost about 13% of their body weight
It targets three hormone receptors: GLP-1, GIP, and GCG, each playing a vital role in regulating hunger and blood sugar levels
This is not just a liquid in a pen
Notably, Arakeri et al
Nasal spray offers an alternative that eliminates these concerns while introducing its own set of considerations